April 1, 2020– The first of April is an opportunity for people to play good-natured pranks on their family and friends. But this year it also gives hospitals participating in the 340B drug pricing program a chance to reflect on something that is definitely not a joke – drug manufacturer pricing transparency has improved because of a federal website that went live a year ago … [Read more...]
MedPAC Report Addresses Key 340B Questions
March 18, 2020– A new report from a respected, independent congressional advisory panel sheds light on several of the key questions surrounding the 340B drug pricing program. In its March 2020 report to Congress, the Medicare Payment Advisory Commission (MedPAC) examined whether participation in the 340B program leads to higher drug spending for Medicare patients with five … [Read more...]
The 340B Proof of Concept: Better Patient Health
December 5, 2019– When policymakers assess whether programs they created are having positive impacts on people and communities, they ask for evidence that things are better than they were before the program took effect. When it comes to the 340B drug pricing program, that proof is in the improved health of patients. A new report by 340B Health has important information about … [Read more...]
340B Provides Better Access to Diabetes Treatment
November 26, 2019– Public attention has increased in recent months to a health access challenge that 340B hospitals have been aware of for years. Many patients with diabetes are struggling to afford the cost of insulin and other expensive treatments they need to manage the disease and stay healthy. But with the help of 340B, many safety-net hospitals are doing great work to … [Read more...]
From the Grassroots: Policymakers Learn About 340B’s Impact
November 21, 2019– Leaders from three 340B hospital systems were on Capitol Hill on Nov. 20 to educate policymakers about the critical role the 340B drug savings program plays in supporting the nation’s health care safety net. An audience of congressional staffers, patient advocates, community leaders, and others attended a special briefing organized by 340B Health to hear … [Read more...]
New Report Misses the Mark on 340B Program
November 19, 2019– The latest report from AIR340B, a group financed and backed by the pharmaceutical industry, again misrepresents the 340B drug pricing program and its long history of helping hospitals stretch scarce resources to better serve low-income and rural patients. As part of its efforts to sharply restrict 340B, the group misleads policymakers and the public by … [Read more...]
Faces of 340B: A Patient Mission Under Duress
November 8, 2019– Like many safety-net health systems, Centura Health has been using the 340B drug pricing program to keep some of its hospitals operating and to serve all patients regardless of their ability to pay. But continuing Medicare cuts to many of these hospitals are straining that important mission. Centura Health is a 17-hospital system located in Colorado and … [Read more...]